Myleran is a chemotherapy drug licensed for the treatment of a certain type of cancer known as chronic myelogenous leukemia. This prescription medicine comes in tablet form and is taken once a day. It works by preventing cancer cells from growing and multiplying. Most people using this drug will develop some type of reaction, such as infections, anemia, or bleeding.
What Is Myleran?
Myleran® (busulfan) is a prescription medication approved to treat chronic myelogenous leukemia, a type of cancer of the blood cells. Chronic myelogenous leukemia is also called chronic myeloid leukemia or chronic granulocytic leukemia. Myleran belongs to a group of chemotherapy medicines known as alkylating agents.
Myleran is manufactured by Excella GmbH for Aspen Global Incorporated and distributed by Prasco Laboratories.
How Does Myleran Work?
Myleran is part of a group of medications called alkylating agents. In general, alkylating agents work by causing strands of DNA to bond to each other and become linked (this is known as "cross-linking"). The linked strands cannot uncoil and separate, which is necessary for the DNA to replicate. Because DNA replication is essential for cells to grow and multiply, alkylating agents like Myleran prevent cell growth and multiplication, and may cause cell death.
Busulfan. Drug Facts and Comparisons. Drug Facts and Comparisons 4.0 [online]. 2012. Available from Wolters Kluwer Health, Inc. Accessed September 6, 2012.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed September 6, 2012.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed September 7. 2012.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed September 7, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click